A Study to Compare the Pharmacokinetics of JHL1149 and Bevacizumab (Avastin) in Healthy Male Volunteers

NCT03576651 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

BIOLOGICAL: JHL1149
BIOLOGICAL: Bevacizumab
BIOLOGICAL: Bevacizumab

Sponsor

JHL Biotech, Inc.